retatrutide triple agonist glp-1 gip glucagon ly3437943 mechanism A review of an investigational drug retatrutide, a novel agent for the treatment of LY3437943, a novel triple glucagon,
Pay in 4 interest-free payments of $6.79 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 10 - Nov 15






















